Royalties and Milestone Payments. EYEFITE shall be obligated to make to PHS, for as long as the PHS Agreement is in effect and obligates CANFITE to make any payments to PHS, the following Royalty, Milestone and Sublicensing payments to PHS under the PHS Agreement, as follows:
Royalties and Milestone Payments. 5.1 (a) The Licensee shall also pay to The Regents an EARNED ROYALTY of [***] of the Net Sales of Licensed Products, provided that the earned royalty shall be [***] of Net Sales of a Licensed Product if Net Sales of the Licensed Product are less than [***] per year in any given calendar year of sales. ***Confidential Treatment Requested 10
Royalties and Milestone Payments. The royalties and Milestone Payments that are payable under the License Agreement shall be as set forth in the License Agreement. For clarity, the Company shall not be required to pay any royalties or Milestone Payments with respect to the Grandfathered AIP Compounds or Grandfathered Intent to Access Compounds.
Royalties and Milestone Payments. 5.1 In consideration of the license granted hereunder, the Licensee shall pay to the University a royalty comprised of [***] of the Revenue.
Royalties and Milestone Payments. 5.1 As part of the consideration for the rights granted by the Licensor to the Licensee under this Agreement, the Licensee will pay to the Licensor, on a quarterly basis, an annual royalty of *****% of annual Net Revenue and *****% of annual Sublicensing Revenue (collectively, the “Royalties”).
Royalties and Milestone Payments. SECTION 6.1 Subject to the terms and conditions of this AGREEMENT, and as consideration for the licenses granted under this AGREEMENT, CUBIST shall pay to the UNIVERSITY an earned royalty of [ * ] of NET SALES of the [ * ] launched by CUBIST [ * ]. CUBIST shall pay to * Confidential Treatment Requested. Omitted portions filed with the Commission. the UNIVERSITY an earned royalty of [ * ] of NET SALES of [ * ] sold by CUBIST [ * ].
Royalties and Milestone Payments. 5.1 In consideration for the licence hereby granted, Biocontrol shall pay to HPA
Royalties and Milestone Payments. 5.1 In consideration of the license granted hereunder, the Licensee shall pay to the University a royalty comprised of 2% of the Revenue.
Royalties and Milestone Payments. 3.1 The Company agrees to pay to Wake Forest an earned royalty at incremental rates based on percentages of Net Sales during each calendar year as follows: On Annual Net Sales Of Royalty Rate ---------------------- ------------ $0 - $10,000,000 3% $10,000,001 - $20,000,000 4% > $20,000,000 5% Notwithstanding the foregoing table, if the Company's Net Sales for any two successive calendar years exceed $25,000,000 in each year, the earned royalty rate for the following and all succeeding years shall be a fixed rate equal to five percent (5%) of Net Sales. No multiple or compounded royalties will be applied on the grounds that a Licensed Product or Licensed Process is covered by more than one Patent Right licensed hereunder.
Royalties and Milestone Payments. 6.1 Royalties- STRAKAN will pay ACCESS a royalty of Ten Percent (10%) of NET SALES in each country of the TERRITORY where there is PATENT protection for the life of the PATENT or where there is MARKET EXCLUSIVITY for the period of such MARKET EXCLUSIVITY and four percent (4%) of NET SALES in each country of the TERRITORY if there is no PATENT protection or MARKET EXCLUSIVITY. These payments are to be made in accord with Article 6.2.
